1) Myeloid leukemia
髓细胞白血病
1.
Objective: To investigate the expression of neuropilin-1 (NP-1) gene in bone marrow stromal cells (BMSCs) from myeloid leukemia (AML and CML) and normal individuals.
目的了解neuropilin-1(NP-1)基因在髓细胞白血病(AML和CML)患者及正常人骨髓基质细胞中的表达情况。
2) bone marrow leukemia cells
骨髓白血病细胞
3) myeloid leukemia cell
髓系白血病细胞
1.
FasL expression was investigated in myeloid leukemia cells and its upregulation by a combination of IL 2 and INF γ, as well as its function of inducing Jurkat cells to apoptosis mainly by flow cytometry (FCM).
为了解Fas配体 (FasL)在髓系白血病细胞中的表达水平及其诱导Fas+敏感细胞发生凋亡的功能 ,用流式细胞术检测 38例髓系白血病患者 (外周血白细胞 >10 0× 10 9/L)的白血病细胞在新鲜分离及IL 2和IFN γ刺激后表面膜FasL的表达水平 ,将白血病细胞 ( 1× 10 6/ml)与Jurkat细胞 ( 1× 10 5/ml)混合培养 2 4小时后 ,用DNA电泳和流式细胞术双标法检测Jurkat细胞发生凋亡的情况。
4) Myeloid Cell Leukemin-1(MCL-1) Protein
髓细胞白血病1蛋白
5) acute myeloid leukemia
急性髓细胞白血病
1.
Prognostic values of lactate dehydrogenase and β_2 microglobulin levels in adult acute myeloid leukemia;
血清乳酸脱氢酶和β_2微球蛋白对急性髓细胞白血病的预后价值
2.
An analysis of 248 cycles of moderate dose cytarabine for acute myeloid leukemia—outcome and side effects;
急性髓细胞白血病缓解后用中剂量阿糖胞苷治疗248个疗程的不良反应分析
3.
Modified FLAG regimen in the management of refractory acute myeloid leukemia;
改良FLAG方案治疗难治性急性髓细胞白血病的初步分析
6) acute myeloid leukemia
急性髓性细胞白血病
1.
Therapeutic effect of priming induction regimen of CAG for newly diagnosed acute myeloid leukemia in elderly patients;
预激方案CAG治疗老年初治急性髓性细胞白血病的疗效
补充资料：白细胞不增多性白血病
白细胞不增多性白血病
病的一种临床类型。此种病人周围血中白细胞不增多，甚至低于正常，血液中较难发现异常幼稚细胞，故又有人称之为"非白血性白血病"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条